Josef Bogenschuetz joins Novalung as Managing Director
As of January 1, 2011, Josef Bogenschütz and Dr. Georg Matheis are joint Managing Directors of Novalung GmbH. Bogenschütz will be specifically responsible for Research & Development, Manufacturing, Quality Management and Finance. This addition underscores the company’s focus on the ongoing and efficient expansion of its portfolio of innovative products designed to replace invasive mechanical ventilation. Nicholas L. Strout remains responsible for the growth of Novalung’s sales activities.
Dr. Georg Matheis, who has been Managing Director of Novalung since its founding in 2003, commented: “I’m truly looking forward to working with Josef Bogenschütz, who brings with him extensive expertise in our core business, the development and manufacturing of artificial lungs.“
Josef Bogenschütz worked together with Georg Matheis at the German company Jostra AG in the field of cardiac surgery before Jostra was sold to Maquet Cardiopulmonary AG eight years ago and Novalung GmbH was spun off as an independent company. During their time together they laid the foundation for the development of the iLA Membrane Ventilator, Novalung’s flagship product for innovative ventilation therapy. “Since that time I have followed Novalung‘s development with great interest“, Bogenschütz says. “Having built up and developed the Cardiopulmonary business at Maquet over the past several years, I am excited at the prospect of using my experience and focus to drive the development and positioning of Novalung as an innovative company in the field of ventilation.” Bogenschütz explains his decision to move to Novalung after eight years at Maquet with his motto: “You have to have a vision for the future to be able to change the present.”
Bogenschütz was most recently President and CEO at Maquet Cardiopulmonary AG. The 45-year-old mechanical engineer began his career in manufacturing management at Bizerba GmbH and Beru AG before entering the medical device field 11 years ago when he joined Jostra AG.
Objective: Replacing the invasive mechanical ventilation
Novalung‘s mission is to create new solutions for the treatment of lung failure with innovative artificial lungs that “breathe” outside the patient’s body. Instead of placing patients in an artificial coma so that they can tolerate mechanical ventilation Novalung products allow patients being awake and to breathe easily and spontaneously. Those innovative technologies open the door for physicians and nurses to the vision of replacing the damaging invasive mechanical ventilation.
Novalung GmbH was founded in Hechingen (Baden-Württemberg, Germany) in 2003 through the fusion of leading German and American technologies in the field of artificial lungs and is now active throughout the world. From the outset Novalung has focused on high-quality development and production “Made in Germany“. Cutting-edge technologies are employed in Novalung’s medtech production facility in the manufacture in particular of the iLA Membrane Ventilator® and NovaPort® vascular access cannulas, both of which have been used to help treat thousands of patients.
The privately funded Novalung GmbH is a fast growing medical technology company based in the area of Heilbronn/Germany and a subsidiary on the campus of the University of Michigan at Ann Arbor, USA.
Mrs Franziska Preissing
Head of Marketing
Im Zukunftspark 1
T. +49 7131 27 06 130
F. +49 7131 27 06 230
M. +49 173 659 85 63
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Josef Bogenschuetz joins Novalung as Managing Director here
News-ID: 158269 • Views: 3675
More Releases from Novalung GmbH
NovaPort twin, the Newest Double-Lumen Cannula, Approved
Novalung adds the unique double-lumen cannula to its expanding portfolio of products for the extrapulmonary treatment of lung failure. Now only a single cannula is required instead of two. Novalung announced today that it has received approval for the new NovaPort twin® double-lumen cannula, which is now available for clinical use. The NovaPort® twin cannula was specifically designed for veno-venous vascular access for the iLA activve® system - the Allrounder for
Novalung receives CE mark for iLA activve®
Novalung receives CE mark for iLA activve® With the new all-rounder for extrapulmonary lung support Novalung GmbH is the only company worldwide offering the complete portfolio for both pumpless and pump-driven lung support. Novalung announces receiving CE mark approval for their new pump-driven iLA activve® lung support system. It will be launched in Europe with immediate effect. Respiratory support with iLA activve® enables a treatment environment with awake, mobile patients instead
Novalung and Medos start cooperation
Due to the acquisition of Medos Medizintechnik AG by the private equity fund Zukunftsfonds Heilbronn (“Future Fund of Heilbronn”) the company will cooperate closely in the future with Novalung GmbH, which is expected to strengthen both medical device companies. The Zukunftsfonds Heilbronn (zfhn) announced that it has acquired Medos Medizintechnik AG from Ventizz Capital Partners Advisory AG. The purchase agreement was signed on January 7, 2011. With this
Novalung GmbH continues expansion into Scandinavia
The world’s first pumpless lung assist device, the iLA Membrane Ventilator®, now exclusively available in Sweden and Norway through Vingmed Group. Novalung GmbH, the German manufacturer of the world’s leading therapeutic system for extrapulmonary lung support, has signed exclusive agreements with Vingmed Svenska AB and Vingmed AS for distribution of the iLA Membrane Ventilator® in Sweden and Norway, respectively. Dr. Torsten Rinne, Medical Director of Novalung GmbH, noted: “We have seen
More Releases for Josef
Josef Woodard's "Ladies Who Lunch" novel successfully launched
Ladies who Lunch by Josef Woodard Publisher: Household Ink Softcover | 6 x 9in | 272 pages | ISBN 9781736165508 E-Book | 272 pages | ISBN 9781736165515 Available at Amazon, Barnes & Noble, and many brick and mortar stores in Santa Barbara, and beyond Price: $17.95, pre-order, $12.95 Website: www.LadiesWhoLunch.me This just in: Ladies Who Lunch has enjoyed a healthy, satisfying launch. The debut novel by Josef Woodard, veteran music/arts scribe, musician/songwriter and general
Global Luxury Pen Market 2018 - Josef Lamy, Elmo Montegrappa, Montblanc Internat …
Eminent Market, recently published a detailed market research study focused on the “Luxury Pen Market” across the global, regional and country level. The report provides 360° analysis of “Luxury Pen Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Luxury Pen on the
Global Solar Control Spandrel Curtain Wall Market Report 2018 : WICONA, UNIGLAS, …
Qyresearchreports include new market research report "Global Solar Control Spandrel Curtain Wall Sales Market Report 2018" to its huge collection of research reports. A holistic and detailed overview of the global Solar Control Spandrel Curtain Wall market that includes information derived from utilizing various quantitative and qualitative analysis techniques has been compiled in this latest market report. This compilation offers its readers a great overview of the Solar Control Spandrel Curtain
Global Solar Control Spandrel Curtain Wall Market 2017 : iconic skin, UNIGLAS, T …
Global Solar Control Spandrel Curtain Wall Market Research Report 2017-2022 A market research based on the "Solar Control Spandrel Curtain Wall Market" across the globe, recently added to the archive of Market Research Explore, is titled ‘Global Solar Control Spandrel Curtain Wall Market 2017’. The research report analyzes the ancient as well as present performance of the global Solar Control Spandrel Curtain Wall market, and makes predictions on the future status
Josef Waclaw, the new CEO of Infotecs GmbH
Berlin, May 31, 2016 – Josef Waclaw is appointed as CEO of Infotecs Internet Security Software GmbH. He is responsible for strengthening the market position and for the strategic expansion of the technology and distribution network in EMEA. Josef Waclaw was appointed to Chief Executive Officer of Infotecs GmbH in Berlin. The new manager is responsible for strategic development of the high security solutions for the EMEA region and the further
Josef Schulz, poststructure
Josef Schulz: “poststructure” Opening Reception: Friday, September 14, 2012, 7pm Exhibition: through November 3, 2012 Paradise Cafe. Property For Sale poststructure by Josef Schulz Abandoned buildings have a charm of their own. In stark contrast to inhabited ones, life has left them, remaining discernible all the same. In our concept of a life lived it remains present as a memory. Abandoned industrial wastelands, too, exude an air of work and manufacture. These new places